One Health Group PLC - Trading Update

One Health Group plc
("One Health", the "Company" or the "Group")
Trading Update
H2 trading remains strong with outlook unchanged
FY 26 Revenue and EBITDA growth remains in-line with expectations
Continued strong growth across all KPIs
One Health Group plc (AIM: OHGR), the independent provider of NHS-funded surgical procedures for patients referred from the NHS through 'Patient Choice', confirms that second half trading remains strong and the business is on track to deliver growth at the revenue and underlying EBITDA levels for the year ending
1Management understands consensus market forecasts for revenue to range from
Update on first new-build surgical hub
The Company has received guidance that the final pre-commencement planning condition sign-off, relating to environmental matters, is expected to be confirmed within the coming weeks, with the remaining six pre-commencement conditions having already been satisfied. The Board remains confident that, once all planning condition signoffs are in place, the project will proceed in line with the anticipated one-year construction timetable, with contractors ready to start immediately. On completion, the new surgical hub is expected to provide significant additional surgical operating capacity and has the potential to materially enhance the Group's revenue and profitability.
Outlook
The Company has seen no change in trading performance towards the end of the financial year and remains well funded to deliver continued organic growth and execute the roll-out of the first surgical hub, accelerating growth and improving profitability. The Board is confident that the business will continue to deliver organic growth through increased new patient referrals, a strong pipeline of new surgeons, and additional surgical capacity in existing and new independent sector hospitals to help deliver on challenging Government Waiting List reduction targets.
"We are delighted that our growth plans remain unaffected by wider concerns of reductions in elective surgery across
"We work very effectively with multiple NHS commissioning bodies across a wide geography in addition to contracts directly with local NHS hospitals to support the reduction of internal 'long waits'. In any case, the vast majority of our activity is from brand new patients referred by their GP directly to One Health by exercising their legal right to choose their provider of care through 'patient choice'. We have seen increasing year on year demand in direct GP referrals as more and more new patients enter the system looking for treatment. As well as increased GP referrals, and as anticipated, we have also seen an increase in NHS hospital referrals in H2 supported by additional funding from the NHS 'quarter four sprint' initiative, where local NHS hospitals transfer NHS patients from their internal patient waiting lists."
"We are very proud to be a trusted provider of support to the NHS for over 21 years, with excellent long-standing relationships, and we continue to look forward to the future with confidence, providing much needed care, free at the point of delivery for NHS patients, across an ever-increasing geography, and reducing pressure on the NHS."
If you wish to keep up to date on Company news please email: onehealth@walbrookpr.com
For more information, please contact:
|
One Health Group plc
|
Via Walbrook PR |
|
|
Panmure Liberum (Nominated Adviser and Broker)
|
Tel: +44 (0)20 3100 2000 |
|
|
Walbrook PR (Media & Investor Relations) |
Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 / +44 (0)7747 515 393 |
|
|
|
|
|
|
|
||
About One Health Group plc (www.onehealth.co.uk)
One Health engages 80 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and, in the year, to
One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is derived from over 60 NHS commissioning bodies in addition to contracts with local NHS Hospital Trusts to transfer their internal waiting list patients to One Health for quicker treatment.
One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology, with urology introduced at the end of FY25.
Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.
Online investor presentation
Click below for the latest online presentation by Derek Bickerstaff, Chairman and Adam Binns, Chief Executive Officer, which offers insights into the Company's growth strategy and long-term vision:
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE